Literature DB >> 33469305

Erratum: LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling [Corrigendum].

.   

Abstract

[This corrects the article DOI: 10.2147/OTT.S258896.].
© 2021 Wang et al.

Entities:  

Year:  2021        PMID： 33469305      PMCID： PMC7811461          DOI： 10.2147/OTT.S299935

Source DB:  PubMed          Journal:  Onco Targets Ther        ISSN： 1178-6930            Impact factor:   4.147


Wang Q, Liao J, He Z, et al. Onco Targets Ther. 2020;13:10983–10994 On page 10993, Funding section, “This study was supported by grants from the Natural Science Foundation of Fujian Province (grant nos. 2017J01261 and 2016JD1488)” should have been “This study was supported by grants from the Natural Science Foundation of Fujian Province (grant nos. 2017J01261 and 2016J01488)”. The authors apologize for this error.
  1 in total

1.  Synergistic Effect of Stereotactic Radiotherapy Combined with Karelizumab on Patients with Advanced NSCLC.

Authors:  Jiayou Guo; Jiayi Guo; Beibei Cheng; Xingbang Sun; Hongwei Zhang; Jianxin Ma
Journal:  J Healthc Eng       Date:  2022-03-08       Impact factor: 2.682
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.